In NSCLC patients, CD4+CD25+ Treg subtype functions were associated with their FoxP3, CTLA-4, and IL-7Rα expression, and their blood levels were correlated with the clinical outcome of the patients. Here, CD4 is linked to non-small cell lung carcinoma.